NCT06032533

Brief Summary

The goal of this clinical trial is to examine the effect of limb occlusion therapy (remote ischemic conditioning, RIC) in subjects with aneurysmal subarachnoid hemorrhage. The main question it aims to answer is whether RIC can improve long-term recovery in participants with aneurysmal subarachnoid hemorrhage. Researchers will compare levels of functional independence in participants in the RIC-group to participants in the sham-group.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
19mo left

Started Sep 2023

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress63%
Sep 2023Nov 2027

First Submitted

Initial submission to the registry

September 5, 2023

Completed
4 days until next milestone

Study Start

First participant enrolled

September 9, 2023

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 13, 2023

Completed
4.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2027

Last Updated

October 3, 2025

Status Verified

September 1, 2025

Enrollment Period

4.2 years

First QC Date

September 5, 2023

Last Update Submit

September 30, 2025

Conditions

Keywords

Remote Ischemic ConditioningSubarachnoid HemorrhageAneurysmDelayed Cerebral Ischemia

Outcome Measures

Primary Outcomes (1)

  • Clinical outcome after 6 months measured by modified Rankin scale score (0-6, Higher score indicates worse outcome)

    Assessed by telephone interview. Patient assessor is blinded to intervention

    Assessed 6 months after initial aneurysm rupture.

Secondary Outcomes (6)

  • Difference in Infarct growth

    MRI performed 4-6 weeks after initial hemorrhage.

  • Clinical outcome after 14 days measured by modified Rankin scale score (0-6, Higher score indicates worse outcome)

    14 days after initial hemorrhage.

  • Occurrence of delayed cerebral ischemia

    Within first 14 days after initial hemorrhage.

  • Mortality after 3 months

    Assessed at 3 months post initial hemorrhage

  • Mortality after 12 months

    Assessed at 12 months post initial hemorrhage

  • +1 more secondary outcomes

Study Arms (2)

Remote Ischemic Conditioning

EXPERIMENTAL

After randomization a large thigh blood pressure cuff will be placed on the lower limb. The cuff will be inflated to a pressure 30 mm Hg greater than the systolic arterial blood pressure measured by the patient's arterial line or upper limb blood pressure cuff. The adequate level of inflation will be confirmed by the absence of pulse in the ipsilateral pedal artery detected by palpation. If the pulse signal is still present, the cuff will be inflated further until it disappears. The cuff will remain inflated for 5 minutes. Then the cuff will be deflated and the limb allowed to re-perfuse for 5 minutes. The procedure will be repeated five times followed by reperfusion. The first session will be performed 24-72 hours after the initial hemorrhage, within the first 24 hours after treatment of aneurysm, and repeated every 24 hours, between 8-10 am, until post hemorrhagic day 14.

Device: Remote Ischemic Conditioning with Automatic Tourniquet Device

Sham-RIC

SHAM COMPARATOR

After randomization a large leg blood pressure cuff will be placed on the lower limb. This cuff will be inflated to 50 mm Hg only. The device will the be operated by trained staff. The cuff will remain inflated for 5 minutes, then the cuff will be deflated for 5 minutes. The procedure will be repeated for five cycles. The first session will be performed 48-72 hours after the initial hemorrhage, at least 24 hours after treatment of aneurysm and repeated every 24 hours, between 8-10 am, until post hemorrhagic day 14.

Device: Sham Remote Ischemic Conditioning with Automatic Tourniquet Device

Interventions

5 Cycles of Remote Ischemic Conditioning performed on the leg. One cycle consists of 5 minutes of arterial occlusion followed by 5 minutes of reperfusion. The above is repeated daily for 14 days or until patient is discharged. Patients are randomized to either active Remote Ischemic Conditioning or Sham-treatment.

Remote Ischemic Conditioning

5 Cycles of sham-treatment performed on the leg. One cycle consists of 5 minutes of sham-treatment followed by 5 minutes of pause. The above is repeated daily for 14 days or until patient is discharged. Patients are randomized to either active Remote Ischemic Conditioning or Sham-treatment.

Also known as: Sham
Sham-RIC

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aneurysmal subarachnoid hemorrhage confirmed by computed tomography (CT) with aneurysm origin confirmed by computed tomography angiography (CTA) or digital subtraction angiography (DSA)
  • Aneurysmal subarachnoid hemorrhage symptom-onset ≤ 3 days
  • Aneurysm protected by clipping or coiling
  • Independent in daily living before symptom onset (mRS ≤ 2)

You may not qualify if:

  • Subarachnoid hemorrhage caused by a lesion other than cerebral aneurysm
  • Symptomatic vasospasm at the time of enrollment
  • Previous cerebral lesion e.g. symptomatic cerebral infarction (\>2cm), multiple sclerosis, symptomatic intracerebral hemorrhage, tumour, prior neurosurgery (excluding prior clipping or coiling of cold aneurysms without complications).
  • History of severe peripheral vascular disease or signs of severe peripheral vascular disease on physical examination
  • History of deep vein thrombosis or signs of deep vein thrombosis on physical examination
  • Kidney involvement or prior kidney disease with an estimated glomerular filtration rate (eGFR) below safe levels for contrast infusion in relation to CT-perfusion.
  • Concomitant other acute life-threatening medical or surgical condition

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Neurosurgery, Aarhus University Hospital

Aarhus N, Danmark, DK-8200, Denmark

RECRUITING

Related Publications (2)

  • Hess DC, Blauenfeldt RA, Andersen G, Hougaard KD, Hoda MN, Ding Y, Ji X. Remote ischaemic conditioning-a new paradigm of self-protection in the brain. Nat Rev Neurol. 2015 Dec;11(12):698-710. doi: 10.1038/nrneurol.2015.223. Epub 2015 Nov 20.

    PMID: 26585977BACKGROUND
  • Gonzalez NR, Connolly M, Dusick JR, Bhakta H, Vespa P. Phase I clinical trial for the feasibility and safety of remote ischemic conditioning for aneurysmal subarachnoid hemorrhage. Neurosurgery. 2014 Nov;75(5):590-8; discussion 598. doi: 10.1227/NEU.0000000000000514.

    PMID: 25072112BACKGROUND

Related Links

MeSH Terms

Conditions

Subarachnoid HemorrhageAneurysm

Condition Hierarchy (Ancestors)

Intracranial HemorrhagesCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesHemorrhagePathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Grethe Andersen, Prof., MD

    Department of Neurology, Aarhus University Hospital

    PRINCIPAL INVESTIGATOR
  • Arzu Bilgin-Freiert, MD, PhD

    Department of Neurosurgery

    STUDY DIRECTOR

Central Study Contacts

Kim M Ørskov, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Outcomes assessors are recruited from another department, and have not been involved with subjects prior to the telephone interview. Participants and outcome assessors are blinded to subject intervention.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants are randomized to either daily treatment with remote ischemic conditioning or daily sham-treatment.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor, Consultant Neurologist, MD

Study Record Dates

First Submitted

September 5, 2023

First Posted

September 13, 2023

Study Start

September 9, 2023

Primary Completion (Estimated)

November 30, 2027

Study Completion (Estimated)

November 30, 2027

Last Updated

October 3, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will share

Individual participant data that underlie the results reported in this article after de-identification of participants

Shared Documents
STUDY PROTOCOL, SAP, ANALYTIC CODE
Time Frame
Beginning 3 moths and ending 5 years following publication of results
Access Criteria
Proposals should be directed to kimoer@rm.dk. To gain access data requestors will need to sign a data processing agreement.

Locations